Target Name: Inositol 1,4,5-Trisphosphate Receptor (InsP3R)
NCBI ID: P40720
Review Report on Inositol 1,4,5-Trisphosphate Receptor (InsP3R) Target / Biomarker Content of Review Report on Inositol 1,4,5-Trisphosphate Receptor (InsP3R) Target / Biomarker
Inositol 1,4,5-Trisphosphate Receptor (InsP3R)
Other Name(s): Inositol 1,4,5-Trisphosphate Receptor | IP3R | InsP3R

Inositol 1,4,5-Trisphosphate Receptor (InsP3R): A Potential Drug Target and Biomarker

Inositol 1,4,5-trisphosphate (InsP3) is a crucial signaling molecule that plays a central role in various physiological processes, including intracellular signaling, neurotransmission, and metabolism. InsP3 signaling has been implicated in numerous diseases, including diabetes, cancer, and neurodegenerative disorders. The Inositol 1,4,5-Trisphosphate Receptor (InsP3R), a G protein-coupled receptor, has been identified as a potential drug target and biomarker for several diseases. In this article, we will discuss the InsP3R, its function, and its potential as a drug target.

Function of InsP3R

InsP3R is a member of the G protein-coupled receptor (GPCR) family, which includes over 700 different genes and is involved in various signaling pathways. InsP3R is a widely expressed receptor with high prevalence in various tissues, including brain, heart, skeletal muscles, and tissues. It is involved in the regulation of intracellular signaling pathways, including cell survival, cell growth, and metabolism.

InsP3R signaling pathway

The InsP3R signaling pathway involves the interaction between InsP3R and various intracellular signaling pathways. The receptor is involved in the regulation of various cellular processes, including cell adhesion, cell survival, and cell growth. InsP3R signaling is tightly regulated by several intracellular factors, including calcium ions (Ca2+), which are essential for the regulation of muscle contractions and cell signaling.

Drugs that bind to InsP3R activate several intracellular signaling pathways, including the calcium ion signaling pathway. This signaling pathway is involved in the regulation of many cellular processes, including muscle contractions, nerve transmission, and hormone signaling. By activating these pathways, drugs can cause a range of cellular and molecular effects, including muscle relaxation, increased appetite, and enhanced sensitivity to pain.

Potential drug targets

The InsP3R is a potential drug target for several diseases. Its involvement in various signaling pathways makes it a promising target for the treatment of diseases associated with the regulation of intracellular signaling pathways. Some of the potential drug targets for InsP3R include:

1. Diabetes: InsP3R is involved in the regulation of insulin signaling, which is crucial for the regulation of blood sugar levels. Diabetes is a disease that is characterized by the failure of the insulin signaling pathway to regulate glucose levels. InsP3R has been shown to play a role in the regulation of insulin sensitivity and glucose metabolism. Drugs that bind to InsP3R and regulate insulin signaling may be effective in the treatment of diabetes.
2. Cancer: InsP3R is involved in the regulation of cell survival and growth, which are crucial factors in the development and progression of cancer. Drugs that bind to InsP3R and inhibit its signaling pathway may be effective in the treatment of cancer.
3. Neurodegenerative disorders: InsP3R is involved in the regulation of neural signaling pathways, which are crucial for the development and progression of neurodegenerative disorders. Drugs that bind to InsP3R and regulate its signaling pathway may be effective in the treatment of neurodegenerative disorders.

Biomarkers for InsP3R

InsP3R is a potential biomarker for several diseases. Its involvement in intracellular signaling pathways makes it a potential target for the detection and diagnosis of various diseases. Some of the biomarkers that may be associated with InsP3R include:

1. Insulin-like growth factor 1 (IGF-1

Protein Name: Inositol 1,4,5-Trisphosphate Receptor (InsP3R) (nonspecified Subtype)

The "Inositol 1,4,5-Trisphosphate Receptor (InsP3R) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Inositol 1,4,5-Trisphosphate Receptor (InsP3R) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Inositol hexakisphosphate kinase | Inositol Monophosphatase | INPP1 | INPP4A | INPP4B | INPP5A | INPP5B | INPP5D | INPP5E | INPP5F | INPP5J | INPP5K | INPPL1 | INS | INS-IGF2 | INSC | INSIG1 | INSIG2 | INSL3 | INSL4 | INSL5 | INSL6 | INSM1 | INSM2 | INSR | INSRR | Insulin-like growth factor | Insulin-like growth factor 2 mRNA binding protein | Insulin-like growth factor 2 mRNA-binding protein 1 (isoform 2) | Insulin-like growth factor-binding protein | INSYN1 | INSYN2A | INSYN2B | Integrator complex | Integrin alpha1beta1 (VLA-1) receptor | Integrin alpha2beta1 (VLA-2) receptor | Integrin alpha2beta3 Receptor | Integrin alpha3beta1 receptor | Integrin alpha4beta1 (VLA-4) receptor | Integrin alpha4beta7 (LPAM-1) receptor | Integrin alpha5beta1 (VLA-5) receptor | Integrin alpha5beta3 receptor | Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15 | INTS2 | INTS3 | INTS4 | INTS4P1 | INTS4P2 | INTS5 | INTS6 | INTS6L | INTS6L-AS1 | INTS6P1 | INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS | Inward Rectifier Potassium Channel | IP6K1 | IP6K2